Genomics

Dataset Information

0

Ena-DATASET-BioMediTech-01-01-2016-11:07:07:068-452 - samples


ABSTRACT: We report the first combined analysis of whole genome sequence, detailed clinical history, and transcriptome sequence of multiple prostate cancer metastases in a single patient (A21). Whole genome and transcriptome sequence was obtained from 9 anatomically separate metastases, and targeted DNA sequencing was performed in cancerous and noncancerous foci within the primary tumor specimen removed 5 years prior to death. Transcriptome analysis revealed increased expression of AR-regulated genes in liver metastases that harbored an AR p.L702H mutation, suggesting a dominant effect by the mutation despite being present in only 1 of an estimated 16 copies per cell. The metastases harbored several alterations to the PI3K/AKT pathway, including a clonal truncal mutation in PIK3CG and present in all metastatic sites studied. The list of truncal genomic alterations shared by all metastases included homozygous deletion of TP53, hemizygous deletion of RB1 and CHD1, and amplification of FGFR1. If the patient were treated today given this knowledge, use of second-generation androgen-directed therapies, cessation of glucocorticoid administration, and therapeutic inhibition of the PI3K/AKT pathway or FGFR1 receptor could provide personalized benefit. Three previously unreported truncal clonal missense mutations (ABCC4 p.R891L, ALDH9A1 p.W89R, and ASNA1 p.P75R) were expressed at the RNA level and assessed as druggable. The truncal status of mutations is critical for actionability, and can only be determined through analysis of multiple sites of metastasis. Our findings suggest that a large set of deeply analyzed cases could serve as powerful guide to more effective prostate cancer basic science and personalized cancer medicine clinical trials.

PROVIDER: EGAD00001001869 | EGA |

REPOSITORIES: EGA

altmetric image

Publications

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.

Bova G Steven GS   Kallio Heini M L HM   Annala Matti M   Kivinummi Kati K   Högnäs Gunilla G   Häyrynen Sergei S   Rantapero Tommi T   Kivinen Virpi V   Isaacs William B WB   Tolonen Teemu T   Nykter Matti M   Visakorpi Tapio T  

Cold Spring Harbor molecular case studies 20160501 3


We report the first combined analysis of whole-genome sequence, detailed clinical history, and transcriptome sequence of multiple prostate cancer metastases in a single patient (A21). Whole-genome and transcriptome sequence was obtained from nine anatomically separate metastases, and targeted DNA sequencing was performed in cancerous and noncancerous foci within the primary tumor specimen removed 5 yr before death. Transcriptome analysis revealed increased expression of androgen receptor (AR)-re  ...[more]

Similar Datasets

2016-01-01 | S-EPMC4853517 | BioStudies
| EGAS00001001659 | EGA
2011-01-01 | S-EPMC3142785 | BioStudies
2014-01-01 | S-EPMC4215833 | BioStudies
2013-01-01 | S-EPMC3686853 | BioStudies
2011-01-01 | S-EPMC3157296 | BioStudies
2015-01-01 | S-EPMC4643059 | BioStudies
2016-01-01 | S-EPMC4891302 | BioStudies
2017-01-01 | S-EPMC5689579 | BioStudies
2014-01-01 | S-EPMC4171630 | BioStudies